Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes



Rating:

Share or cite this content

Citations should be made in the following way:
R. Baughman (Cincinnati, United States Of America). Targeting TNF-alpha in inflammatory lung diseases. Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes

Member's Comments

No comment yet.

Related content which might interest you: The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001 Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001 Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006 How systemic inflammatory diseases affect the lung Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Epithelial derived cytokines IL-25, IL-33 and TSLP in obstructive lung diseases Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Interleukin-22 (IL-22) in inflammatory lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 587s Year: 2003 Chemokines induced in human lung epithelial cells by inflammatory cytokines Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease Source: Eur Respir Monogr 2022; 95: 219-237 Year: 2022 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 148s Year: 2004 Assessment of anti-inflammatory cytokines in professional lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 148s Year: 2005